Clinical Trial Update: Study of SPG302 in Healthy Volunteers and ALS Participants [Phase 1]

View source ↗

Summary

Phase 1 trial of SPG302 in healthy volunteers and ALS participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• SPG302

Snippet

Sponsor: Spinogenix | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED